HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Jiang Selected Research

Radiotherapy

1/2022Prediction of the Mechanism of Sodium Butyrate against Radiation-Induced Lung Injury in Non-Small Cell Lung Cancer Based on Network Pharmacology and Molecular Dynamic Simulations and Molecular Dynamic Simulations.
1/2022Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer.
12/2021Platinum-crosslinking polymeric nanoparticle for synergetic chemoradiotherapy of nasopharyngeal carcinoma.
8/2021Tumor treating fields combined with a poly (adenosine diphosphate-ribose) polymerase inhibitor during radiotherapy for rapidly progressing IDH-wildtype diffuse astrocytoma: a case report.
5/2021Nano-enabled coordination platform of bismuth nitrate and cisplatin prodrug potentiates cancer chemoradiotherapy via DNA damage enhancement.
2/2021PD-1 restrains IL-17A production from γδ T cells to modulate acute radiation-induced lung injury.
1/2021Comparison of Dosimetric Benefits of Three Precise Radiotherapy Techniques in Nasopharyngeal Carcinoma Patients Using a Priority-Classified Plan Optimization Model.
1/2021Hypoxic Tumor Radiosensitization Using Engineered Probiotics.
1/2021Strategies of Alleviating Tumor Hypoxia and Enhancing Tumor Therapeutic Effect by Macromolecular Nanomaterials.
1/2021Impact of the weekday of the first intensity-modulated radiotherapy treatment on the survival outcomes of patients with nasopharyngeal carcinoma: A multicenter cohort study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Jiang Research Topics

Disease

431Neoplasms (Cancer)
11/2022 - 05/2002
81Inflammation (Inflammations)
09/2022 - 10/2002
71Infections
09/2022 - 01/2008
56Carcinogenesis
06/2022 - 12/2002
50Hepatocellular Carcinoma (Hepatoma)
01/2022 - 12/2003
48Neoplasm Metastasis (Metastasis)
05/2022 - 05/2002
41Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 11/2005
39Fibrosis (Cirrhosis)
06/2022 - 10/2002
38Breast Neoplasms (Breast Cancer)
06/2022 - 10/2004
36Hypoxia (Hypoxemia)
03/2022 - 08/2010
28Pain (Aches)
01/2022 - 05/2008
27Ovarian Neoplasms (Ovarian Cancer)
06/2022 - 10/2005
27Adenocarcinoma
01/2022 - 10/2005
26Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 09/2002
24Lung Neoplasms (Lung Cancer)
01/2022 - 05/2003
22Body Weight (Weight, Body)
05/2022 - 07/2011
22Nasopharyngeal Carcinoma
01/2022 - 03/2014
22Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 06/2004
21Carcinoma (Carcinomatosis)
03/2022 - 05/2003
19Reperfusion Injury
08/2022 - 03/2008
19Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 06/2004
19Heart Failure
01/2022 - 01/2002
19Prostatic Neoplasms (Prostate Cancer)
01/2021 - 05/2014
18Necrosis
05/2022 - 10/2002
18Sepsis (Septicemia)
01/2022 - 05/2004
18Wounds and Injuries (Trauma)
01/2022 - 02/2007
16COVID-19
08/2022 - 01/2020
16Insulin Resistance
02/2022 - 12/2010
16Atherosclerosis
01/2022 - 03/2007
16Obesity
01/2022 - 12/2010
15Stroke (Strokes)
07/2022 - 07/2006
14Neuralgia (Stump Neuralgia)
12/2020 - 01/2011
13Neuroinflammatory Diseases
10/2022 - 10/2014
13Acute Kidney Injury (Acute Renal Failure)
09/2022 - 06/2017
13HIV Infections (HIV Infection)
06/2022 - 06/2006
13Ischemia
04/2021 - 08/2005
13Heart Diseases (Heart Disease)
01/2018 - 11/2005
12Non-alcoholic Fatty Liver Disease
05/2022 - 06/2011
12Alzheimer Disease (Alzheimer's Disease)
01/2022 - 04/2013
12Glioma (Gliomas)
12/2021 - 03/2008
12Disease Progression
12/2021 - 05/2009
12Human Influenza (Influenza)
03/2021 - 09/2010
12Chronic Hepatitis B
01/2021 - 01/2012
12Osteosarcoma (Osteogenic Sarcoma)
01/2021 - 05/2002
11Hemorrhage
07/2022 - 03/2008
11Rectal Neoplasms (Rectal Cancer)
07/2022 - 12/2012
11Acute Lung Injury
03/2022 - 04/2015
11Lymphatic Metastasis
12/2021 - 09/2010
11Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 05/2008
11Stomach Neoplasms (Stomach Cancer)
11/2021 - 03/2013
11Pancreatic Neoplasms (Pancreatic Cancer)
11/2021 - 01/2012
11Adenocarcinoma of Lung
01/2021 - 06/2003
11Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2008

Drug/Important Bio-Agent (IBA)

122Proteins (Proteins, Gene)FDA Link
09/2022 - 10/2002
82Pharmaceutical PreparationsIBA
09/2022 - 12/2004
71MicroRNAs (MicroRNA)IBA
06/2022 - 09/2010
57Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2011
44CytokinesIBA
01/2022 - 05/2005
40DNA (Deoxyribonucleic Acid)IBA
03/2022 - 12/2002
36Messenger RNA (mRNA)IBA
10/2022 - 06/2003
35LipidsIBA
03/2022 - 08/2008
34Therapeutic UsesIBA
08/2022 - 01/2002
29EnzymesIBA
11/2022 - 01/2005
29CollagenIBA
07/2022 - 04/2003
29Biological ProductsIBA
04/2022 - 04/2005
27Long Noncoding RNAIBA
04/2022 - 04/2013
26Glucose (Dextrose)FDA LinkGeneric
07/2022 - 12/2010
23RNA (Ribonucleic Acid)IBA
01/2022 - 08/2005
22Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 08/2010
21InflammasomesIBA
09/2022 - 06/2013
21Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2008
20LipopolysaccharidesIBA
04/2022 - 04/2009
20LigandsIBA
02/2021 - 05/2002
19Antiviral Agents (Antivirals)IBA
01/2022 - 10/2009
19Peptides (Polypeptides)IBA
01/2022 - 02/2004
19Oxygen (Dioxygen)IBA
01/2022 - 01/2012
18Morphine (MS Contin)FDA LinkGeneric
10/2022 - 04/2009
16AntigensIBA
05/2022 - 01/2011
16Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 06/2006
14AntibodiesIBA
11/2022 - 01/2011
14AntioxidantsIBA
07/2022 - 01/2016
14Cisplatin (Platino)FDA LinkGeneric
06/2022 - 05/2003
14CholesterolIBA
05/2022 - 08/2008
14EscitalopramFDA Link
01/2022 - 01/2012
13VaccinesIBA
11/2022 - 01/2012
13AutoantibodiesIBA
01/2022 - 05/2012
13Circular RNAIBA
01/2022 - 01/2019
13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 05/2003
12Analgesics (Analgesic Drugs)IBA
10/2022 - 05/2008
12ProdrugsIBA
05/2022 - 12/2006
11PlatinumIBA
05/2022 - 01/2009
11CateninsIBA
04/2022 - 06/2012

Therapy/Procedure

209Therapeutics
11/2022 - 05/2002
57Drug Therapy (Chemotherapy)
06/2022 - 07/2011
52Radiotherapy
01/2022 - 09/2010
19Chemoradiotherapy
05/2022 - 07/2011
15Neoadjuvant Therapy
07/2022 - 01/2013
13Aftercare (After-Treatment)
01/2022 - 08/2010
13Ligation
01/2021 - 08/2008
12Immunotherapy
05/2022 - 06/2019